Logo image of ANTA

ANTALPHA PLATFORM HLDNG CO-A (ANTA) Stock Fundamental Analysis

USA - NASDAQ:ANTA - KYG0395R1065 - Common Stock

11.935 USD
+0.05 (+0.46%)
Last: 9/26/2025, 1:52:19 PM
Fundamental Rating

3

ANTA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Consumer Finance industry. Both the profitability and financial health of ANTA have multiple concerns. ANTA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ANTA had positive earnings in the past year.
ANTA Yearly Net Income VS EBIT VS OCF VS FCFANTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 -5M -10M

1.2 Ratios

ANTA has a worse Return On Assets (0.26%) than 65.45% of its industry peers.
Looking at the Return On Equity, with a value of 5.02%, ANTA is doing worse than 61.82% of the companies in the same industry.
ANTA has a Return On Invested Capital (0.92%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.26%
ROE 5.02%
ROIC 0.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANTA Yearly ROA, ROE, ROICANTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -20 -40

1.3 Margins

The Profit Margin of ANTA (8.94%) is comparable to the rest of the industry.
The Operating Margin of ANTA (4.75%) is comparable to the rest of the industry.
ANTA's Gross Margin of 50.15% is in line compared to the rest of the industry. ANTA outperforms 49.09% of its industry peers.
Industry RankSector Rank
OM 4.75%
PM (TTM) 8.94%
GM 50.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANTA Yearly Profit, Operating, Gross MarginsANTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ANTA is destroying value.
The number of shares outstanding for ANTA remains at a similar level compared to 1 year ago.
The debt/assets ratio for ANTA has been reduced compared to a year ago.
ANTA Yearly Shares OutstandingANTA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M
ANTA Yearly Total Debt VS Total AssetsANTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

A Debt/Equity ratio of 1.20 is on the high side and indicates that ANTA has dependencies on debt financing.
With a Debt to Equity ratio value of 1.20, ANTA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.1
WACC9.28%
ANTA Yearly LT Debt VS Equity VS FCFANTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M

2.3 Liquidity

ANTA has a Current Ratio of 1.05. This is a normal value and indicates that ANTA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.05, ANTA perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
ANTA has a Quick Ratio of 1.05. This is a normal value and indicates that ANTA is financially healthy and should not expect problems in meeting its short term obligations.
ANTA has a Quick ratio (1.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
ANTA Yearly Current Assets VS Current LiabilitesANTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 166.71% over the past year.
ANTA shows a strong growth in Revenue. In the last year, the Revenue has grown by 320.96%.
EPS 1Y (TTM)166.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)320.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ANTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.81% yearly.
Based on estimates for the next years, ANTA will show a very strong growth in Revenue. The Revenue will grow by 50.51% on average per year.
EPS Next Y103.79%
EPS Next 2Y141.77%
EPS Next 3Y65.81%
EPS Next 5YN/A
Revenue Next Year65.94%
Revenue Next 2Y62.64%
Revenue Next 3Y50.51%
Revenue Next 5YN/A

3.3 Evolution

ANTA Yearly Revenue VS EstimatesANTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M
ANTA Yearly EPS VS EstimatesANTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 54.25 indicates a quite expensive valuation of ANTA.
ANTA's Price/Earnings ratio is a bit more expensive when compared to the industry. ANTA is more expensive than 78.18% of the companies in the same industry.
When comparing the Price/Earnings ratio of ANTA to the average of the S&P500 Index (27.06), we can say ANTA is valued expensively.
The Price/Forward Earnings ratio is 10.73, which indicates a very decent valuation of ANTA.
The rest of the industry has a similar Price/Forward Earnings ratio as ANTA.
The average S&P500 Price/Forward Earnings ratio is at 22.64. ANTA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 54.25
Fwd PE 10.73
ANTA Price Earnings VS Forward Price EarningsANTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ANTA is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 267.5
ANTA Per share dataANTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ANTA's earnings are expected to grow with 65.81% in the coming years.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y141.77%
EPS Next 3Y65.81%

0

5. Dividend

5.1 Amount

No dividends for ANTA!.
Industry RankSector Rank
Dividend Yield N/A

ANTALPHA PLATFORM HLDNG CO-A

NASDAQ:ANTA (9/26/2025, 1:52:19 PM)

11.935

+0.05 (+0.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.58%
Ins Owner ChangeN/A
Market Cap282.62M
Analysts85
Price Target19.64 (64.56%)
Short Float %N/A
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.8%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.71%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 54.25
Fwd PE 10.73
P/S 4.96
P/FCF N/A
P/OCF N/A
P/B 2.79
P/tB 2.79
EV/EBITDA 267.5
EPS(TTM)0.22
EY1.84%
EPS(NY)1.11
Fwd EY9.32%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.41
BVpS4.28
TBVpS4.28
PEG (NY)0.52
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.26%
ROE 5.02%
ROCE 1.04%
ROIC 0.92%
ROICexc 1.06%
ROICexgc 1.06%
OM 4.75%
PM (TTM) 8.94%
GM 50.15%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF N/A
Debt/EBITDA 34.31
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z N/A
F-ScoreN/A
WACC9.28%
ROIC/WACC0.1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y103.79%
EPS Next 2Y141.77%
EPS Next 3Y65.81%
EPS Next 5YN/A
Revenue 1Y (TTM)320.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year65.94%
Revenue Next 2Y62.64%
Revenue Next 3Y50.51%
Revenue Next 5YN/A
EBIT growth 1Y141.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year463.36%
EBIT Next 3Y126.9%
EBIT Next 5YN/A
FCF growth 1Y3.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.46%
OCF growth 3YN/A
OCF growth 5YN/A